Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

Cited In for PubMed (Select 20074533)

1.

Fetal stem cells and skeletal muscle regeneration: a therapeutic approach.

Pozzobon M, Franzin C, Piccoli M, De Coppi P.

Front Aging Neurosci. 2014 Aug 27;6:222. doi: 10.3389/fnagi.2014.00222. eCollection 2014. Review.

2.

Counteracting the enzymatic activity of dipeptidylpeptidase 4 for potential therapeutic advantage, with an emphasis on cord blood transplantation.

Broxmeyer HE.

Korean J Intern Med. 2013 Nov;28(6):639-45. doi: 10.3904/kjim.2013.28.6.639. Epub 2013 Oct 29. Review.

3.

Umbilical cord blood transplantation: the first 25 years and beyond.

Ballen KK, Gluckman E, Broxmeyer HE.

Blood. 2013 Jul 25;122(4):491-8. doi: 10.1182/blood-2013-02-453175. Epub 2013 May 14. Review.

4.

Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types.

Ou X, O'Leary HA, Broxmeyer HE.

Blood. 2013 Jul 11;122(2):161-9. doi: 10.1182/blood-2013-02-487470. Epub 2013 May 1. Review.

5.

Few single nucleotide variations in exomes of human cord blood induced pluripotent stem cells.

Su RJ, Yang Y, Neises A, Payne KJ, Wang J, Viswanathan K, Wakeland EK, Fang X, Zhang XB.

PLoS One. 2013;8(4):e59908. doi: 10.1371/journal.pone.0059908. Epub 2013 Apr 1.

6.

Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming.

Lee MR, Prasain N, Chae HD, Kim YJ, Mantel C, Yoder MC, Broxmeyer HE.

Stem Cells. 2013 Apr;31(4):666-81. doi: 10.1002/stem.1302.

7.

Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.

Ramos-Mejía V, Montes R, Bueno C, Ayllón V, Real PJ, Rodríguez R, Menendez P.

PLoS One. 2012;7(4):e35824. doi: 10.1371/journal.pone.0035824. Epub 2012 Apr 24.

8.

Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone.

Meng X, Neises A, Su RJ, Payne KJ, Ritter L, Gridley DS, Wang J, Sheng M, Lau KH, Baylink DJ, Zhang XB.

Mol Ther. 2012 Feb;20(2):408-16. doi: 10.1038/mt.2011.258. Epub 2011 Nov 22.

9.

Human induced pluripotent cells resemble embryonic stem cells demonstrating enhanced levels of DNA repair and efficacy of nonhomologous end-joining.

Fan J, Robert C, Jang YY, Liu H, Sharkis S, Baylin SB, Rassool FV.

Mutat Res. 2011 Aug 1;713(1-2):8-17. doi: 10.1016/j.mrfmmm.2011.05.018. Epub 2011 Jun 28.

10.

Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood.

Broxmeyer HE, Lee MR, Hangoc G, Cooper S, Prasain N, Kim YJ, Mallett C, Ye Z, Witting S, Cornetta K, Cheng L, Yoder MC.

Blood. 2011 May 5;117(18):4773-7. doi: 10.1182/blood-2011-01-330514. Epub 2011 Mar 10.

11.

Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.

Kim YJ, Broxmeyer HE.

Crit Rev Oncol Hematol. 2011 Aug;79(2):112-26. doi: 10.1016/j.critrevonc.2010.07.009. Epub 2010 Aug 19. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk